278 related articles for article (PubMed ID: 38611065)
21. STAT Signaling in Glioma Cells.
Swiatek-Machado K; Kaminska B
Adv Exp Med Biol; 2020; 1202():203-222. PubMed ID: 32034715
[TBL] [Abstract][Full Text] [Related]
22. [STAT proteins in cancerogenesis and therapy of malignancies].
Konjević G
Srp Arh Celok Lek; 2009; 137(1-2):98-105. PubMed ID: 19370975
[TBL] [Abstract][Full Text] [Related]
23. STAT-mediated EGFR signaling in cancer.
Quesnelle KM; Boehm AL; Grandis JR
J Cell Biochem; 2007 Oct; 102(2):311-9. PubMed ID: 17661350
[TBL] [Abstract][Full Text] [Related]
24. Identification of STAT1 and STAT3 specific inhibitors using comparative virtual screening and docking validation.
Szelag M; Czerwoniec A; Wesoly J; Bluyssen HA
PLoS One; 2015; 10(2):e0116688. PubMed ID: 25710482
[TBL] [Abstract][Full Text] [Related]
25. The role of STATs in apoptosis.
Battle TE; Frank DA
Curr Mol Med; 2002 Jun; 2(4):381-92. PubMed ID: 12108949
[TBL] [Abstract][Full Text] [Related]
26. Comprehensive meta-analysis of Signal Transducers and Activators of Transcription (STAT) genomic binding patterns discerns cell-specific cis-regulatory modules.
Kang K; Robinson GW; Hennighausen L
BMC Genomics; 2013 Jan; 14():4. PubMed ID: 23324445
[TBL] [Abstract][Full Text] [Related]
27. A new triazolyl-indolo-quinoxaline induces apoptosis in gastric cancer cells by abrogating the STAT3/5 pathway through upregulation of PTPεC.
Suresh RN; Jung YY; Mohan CD; Gowda SV; Harsha KB; Mantelingu K; Sethi G; Ahn KS; Rangappa KS
Drug Dev Res; 2023 Dec; 84(8):1724-1738. PubMed ID: 37756467
[TBL] [Abstract][Full Text] [Related]
28. STAT proteins as novel targets for cancer drug discovery.
Turkson J
Expert Opin Ther Targets; 2004 Oct; 8(5):409-22. PubMed ID: 15469392
[TBL] [Abstract][Full Text] [Related]
29. Lung cancer treatment potential and limits associated with the STAT family of transcription factors.
Faida P; Attiogbe MKI; Majeed U; Zhao J; Qu L; Fan D
Cell Signal; 2023 Sep; 109():110797. PubMed ID: 37423343
[TBL] [Abstract][Full Text] [Related]
30. Differential constitutive activation between STAT-related proteins and MAP kinase in primary acute myelogenous leukaemia.
Hayakawa F; Towatari M; Iida H; Wakao H; Kiyoi H; Naoe T; Saito H
Br J Haematol; 1998 Jun; 101(3):521-8. PubMed ID: 9633897
[TBL] [Abstract][Full Text] [Related]
31. Constitutive STAT5 activation correlates with better survival in cervical cancer patients treated with radiation therapy.
Chen HH; Chou CY; Wu YH; Hsueh WT; Hsu CH; Guo HR; Lee WY; Su WC
Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):658-66. PubMed ID: 21300446
[TBL] [Abstract][Full Text] [Related]
32. Direct Targeting Options for STAT3 and STAT5 in Cancer.
Orlova A; Wagner C; de Araujo ED; Bajusz D; Neubauer HA; Herling M; Gunning PT; Keserű GM; Moriggl R
Cancers (Basel); 2019 Dec; 11(12):. PubMed ID: 31817042
[TBL] [Abstract][Full Text] [Related]
33. Transcription Factor STAT3 as a Novel Molecular Target for Cancer Prevention.
Xiong A; Yang Z; Shen Y; Zhou J; Shen Q
Cancers (Basel); 2014 Apr; 6(2):926-57. PubMed ID: 24743778
[TBL] [Abstract][Full Text] [Related]
34. Review of STAT3 (Signal Transducers and Activators of Transcription) in head and neck cancer.
Mali SB
Oral Oncol; 2015 Jun; 51(6):565-9. PubMed ID: 25817923
[TBL] [Abstract][Full Text] [Related]
35. STAT3 Interactors as Potential Therapeutic Targets for Cancer Treatment.
Laudisi F; Cherubini F; Monteleone G; Stolfi C
Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29914167
[TBL] [Abstract][Full Text] [Related]
36. Signal transducer and activator of transcription 5 (STAT5), a crucial regulator of immune and cancer cells.
Wittig I; Groner B
Curr Drug Targets Immune Endocr Metabol Disord; 2005 Dec; 5(4):449-63. PubMed ID: 16375697
[TBL] [Abstract][Full Text] [Related]
37. Multiple signaling pathways induced by granulocyte colony-stimulating factor involving activation of JAKs, STAT5, and/or STAT3 are required for regulation of three distinct classes of immediate early genes.
Tian SS; Tapley P; Sincich C; Stein RB; Rosen J; Lamb P
Blood; 1996 Dec; 88(12):4435-44. PubMed ID: 8977235
[TBL] [Abstract][Full Text] [Related]
38. Interpretation of cytokine signaling through the transcription factors STAT5A and STAT5B.
Hennighausen L; Robinson GW
Genes Dev; 2008 Mar; 22(6):711-21. PubMed ID: 18347089
[TBL] [Abstract][Full Text] [Related]
39. Nucleic acid-based approaches to STAT inhibition.
Sen M; Grandis JR
JAKSTAT; 2012 Oct; 1(4):285-91. PubMed ID: 24058785
[TBL] [Abstract][Full Text] [Related]
40. Balancing STAT Activity as a Therapeutic Strategy.
Polak KL; Chernosky NM; Smigiel JM; Tamagno I; Jackson MW
Cancers (Basel); 2019 Nov; 11(11):. PubMed ID: 31684144
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
